| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |